Vitamin Deficiency May Worsen Pain During Healing

Hepatitis B surface antibody, also known as anti-HBs, is a protein produced by the immune system in response to the hepatitis B surface antigen. This antibody test is one of the most important laboratory markers used to determine immunity to hepatitis B virus. The presence of this antibody indicates either successful recovery from a past hepatitis B infection or effective immunization through the hepatitis B vaccine. Testing for hepatitis B surface antibody is commonly performed to assess immune status before potential exposure to the virus or to confirm that vaccination has provided adequate protection.

The hepatitis B surface antibody test is typically ordered in several clinical situations. Healthcare workers and others at high risk of exposure to blood or body fluids often need this test to verify their immunity status. It is also recommended for individuals who have completed the hepatitis B vaccination series to ensure they have developed protective antibody levels. Additionally, the test may be performed on people who have been exposed to hepatitis B virus to determine if they have immunity or need post-exposure prophylaxis. Pregnant women may also be tested as part of routine prenatal screening to assess their hepatitis B status comprehensively.

The test is performed using a blood sample drawn from a vein, usually in the arm. No special preparation is typically required before the test. Results are reported as either positive or negative, with positive results indicating the presence of protective antibodies. A positive anti-HBs result generally means the person is immune to hepatitis B infection and is not at risk of developing the disease. The antibody level may also be measured quantitatively, with levels of 10 milli-international units per milliliter or higher generally considered protective.

Interpreting hepatitis B surface antibody results should be done in conjunction with other hepatitis B markers for a complete picture of infection status. A positive anti-HBs with negative hepatitis B surface antigen and negative hepatitis B core antibody typically indicates immunity from vaccination. If both anti-HBs and hepatitis B core antibody are positive while surface antigen is negative, this usually indicates recovery from past infection with resulting immunity. Healthcare providers use these test results to make decisions about vaccination needs, risk of infection, and appropriate preventive measures for individuals who may be exposed to hepatitis B virus.